(Q40741662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Paula Colmenero

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Margaret Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Esmeralda Castaños-Velez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Mikael Jondal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

554-560

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920615%20AND%20SRC:MED&resulttype=core&format=json

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

8 December 2019

cites work

1 reference

The makings of a tumor rejection antigen

21 January 2018

1 reference

Tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

How tumors escape immune destruction and what we can do about it.

21 January 2018

1 reference

Recombinant viruses as a tool for therapeutic vaccination against human cancers

21 January 2018

1 reference

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

21 January 2018

1 reference

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

21 January 2018

1 reference

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

21 January 2018

1 reference

The role of natural killer cells in immune surveillance of cancer

21 January 2018

1 reference

The anti-tumor effect of recombinant interferon alpha or gamma is influenced by tumor location

21 January 2018

1 reference

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

21 January 2018

1 reference

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

21 January 2018

1 reference

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

21 January 2018

1 reference

The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.

21 January 2018

1 reference

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

21 January 2018

1 reference

Membrane fusion process of Semliki Forest virus. II: Cleavage-dependent reorganization of the spike protein complex controls virus entry

21 January 2018

1 reference

Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.

21 January 2018

1 reference

T cell defined tumor antigens

21 January 2018

1 reference

Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography

21 January 2018

1 reference

Cancer therapy using a self-replicating RNA vaccine

21 January 2018

1 reference

Death mechanisms in cultured cells infected by Semliki Forest virus

21 January 2018

1 reference

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

Tolerance, danger, and the extended family

21 January 2018

1 reference

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

21 January 2018

1 reference

Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors

21 January 2018

1 reference

Inhibition of angiogenesis in vivo by interleukin 12.

21 January 2018

1 reference

The Semliki Forest virus vector induces p53-independent apoptosis

21 January 2018

1 reference

Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815

21 January 2018

1 reference

The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection

21 January 2018

1 reference

Identification and characterization of the tumor-specific P1A gene product

21 January 2018

1 reference